Income Statement
NEUROPACE INC
NPCE
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
99.99 | 79.91 | 65.42 | 45.52 | 45.18 |
|
Cost of Revenue
|
22.77 | 20.82 | 17.30 | 13.03 | 11.75 |
|
Gross Profit
|
77.22 | 59.09 | 48.12 | 32.49 | 33.44 |
|
Operating Expenses
|
93.56 | 80.76 | 75.30 | 73.29 | 57.17 |
|
Research & Development
|
27.89 | 23.65 | 20.78 | 21.95 | 18.21 |
|
Selling, General & Administrative
|
46.58 | 57.10 | 54.52 | 51.34 | 38.96 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-16.34 | -21.67 | -27.17 | -40.79 | -23.74 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
2.82 | 3.02 | 3.05 | 1.58 | 0.45 |
|
Interest Expense
|
3.70 | 8.80 | 8.52 | 7.53 | 7.41 |
|
Other Non-Op Income / Expense
|
-0.49 | 0.30 | -0.32 | -0.34 | -5.38 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-21.47 | -27.14 | -32.96 | -47.08 | -36.08 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-16.34 | -21.67 | -27.17 | -40.79 | -23.74 |
|
Earnings Per Share (Basic)
|
-0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
|
Diluted EPS
|
-0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
|
Weighted Average Shares
|
32.72 | 29.13 | 25.85 | 24.59 | 16.61 |
|
Diluted Weighted Avg Shares
|
32.72 | 29.13 | 25.85 | 24.59 | 16.61 |
|
Comprehensive Income
|
- | - | -32.96 | -47.92 | -36.39 |